Cartesian Therapeutics is a clinical-stage company developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead asset, Descartes-08, is an mRNA CAR-T in Phase 2b ...

Phase 2b study will evaluate the safety, immunogenicity and efficacy of Vaxart’s next generation oral pill COVID-19 vaccine compared to an approved mRNA vaccine comparator — — The sentinel cohort is ...

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) and Moderna, Inc. (NASDAQ:MRNA) have reached a stipulation in their ongoing ...

CAMBRIDGE, MA / ACCESSWIRE / October 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that Abbas Hussain, former Chief ...

马萨诸塞州剑桥市 - mRNA疗法和疫苗领域的先驱Moderna Inc (NASDAQ:MRNA)今日宣布，前Vifor Pharma首席执行官和葛兰素史克制药和疫苗全球总裁Abbas Hussain已被任命为公司董事会成员。

Let the good times roll. The S&P 500 has soared nearly 21% in 2024, including a 2% gain in September. What's especially noteworthy is that the bull market has broadened to include more than only ...

Pfizer Inc (NYSE: PFE) made a promise to outdo cancer, joining its Covid vaccine-peer, Moderna Inc (NASDAQ: MRNA) in turning ...

We recently compiled a list of 10 Worst Performing Stocks to Buy on the Dip. In this article, we will look at where Moderna, ...

CAMBRIDGE, MA and TAIPEI, TAIWAN / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (Nasdaq:MRNA) and Cenra Healthcare, the sales and marketing arm of Cenra Inc., today announced that the companies ...

CSL Ltd. (CMXHF.PK) and Arcturus Therapeutics Holdings Inc. (ARCT), Monday announced that self-amplifying or sa-mRNA COVID-19 vaccine ...

马萨诸塞州剑桥市 - Moderna Inc (NASDAQ:MRNA) 已启动其诺如病毒疫苗候选物的3期临床试验，这标志着解决该病毒所带来的广泛公共卫生问题迈出了重要一步。今天，美国第一位参与者接受了疫苗候选物mRNA-1403的剂量，作为Nova ...

CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the first participant in the U.S. has been dosed in the Nova 301 Trial, a pivotal Phase 3 randomized ...